Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2023

May 5, 2023

284_dirs_2023-05-04_b29d336f-0e2d-472f-b372-2579e997071a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-05-02

Reporting Person: Williams David Michael (EVP,Chief Info&Digital Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-02 Stock Option (Right to Buy) $117.89 A 19364 Acquired 2033-05-01 Common Stock (19364) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11058.96 Direct

Footnotes

F1: The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.